Article Cited by others

ORIGINAL ARTICLE

TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression

Hu Yue-Mei, Lou Xiao-Li, Liu Bao-Zhu, Sun Li, Wan Shan, Wu Lei, Zhao Xin, Zhou Qing, Sun Mao-Min, Tao Kun, Zhang Yong-Sheng, Wang Shou-Li

Year : 2021| Volume: 23| Issue : 2 | Page no: 188-196

   This article has been cited by
 
1 Transforming growth factor-beta (TGF-) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, Ali Zarrabi, Michael R. Hamblin, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Kiavash Hushmandi, Alan Prem Kumar, Navid Rabiee, Milad Ashrafizadeh, Saeed Samarghandian
International Journal of Biological Macromolecules. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
Bo Zhou, Jie Zhang, Hongda Zhu, Shugeng Wu, Alamgeer Yuchi
Journal of Oncology. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
3 MicroRNA-195-5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1
Bin Chen, Guohui Bai, Xiaoyan Ma, Lulin Tan, Houqiang Xu
Oncology Reports. 2021; 46(6)
[Pubmed]  [Google Scholar] [DOI]
4 E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B
Guodong Liu,Xiwu Ouyang,Liansheng Gong,Lei Yao,Shiqing Liu,Jiarong Li,Qi Zhang,Yao Xiao
Molecular Therapy - Nucleic Acids. 2021; 26: 104
[Pubmed]  [Google Scholar] [DOI]
5 Fresh vs frozen testicular sperm for assisted reproductive technology in patients with non-obstructive azoospermia: A systematic review
Medhat Amer,Emad Fakhry
Arab Journal of Urology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article